There is evidence that some complementary and alternative treatments improve physiological abnormalities in autism and thus hold promise for improving symptoms.
AMA J Ethics. 2015;17(4):369-374. doi:
10.1001/journalofethics.2015.17.4.sect1-1504.
Drawing Autism, a collection of drawings and paintings by people diagnosed with autism, demonstrates an array of talent and themes as well as providing insight into the artists and autism spectrum disorder.
AMA J Ethics. 2015;17(4):359-361. doi:
10.1001/journalofethics.2015.17.4.imhl1-1504.
Marwan Hariz, MD, PhD and Jordan P. Amadio, MD, MBA
Deep brain stimulation (DBS) for enhancements of non-disease states is ethically indefensible given our incomplete knowledge of this technology. Attention should instead be focused on increasing access to DBS for patients with illnesses potentially treatable by the procedure.
Reducing racial disparities in pain treatment requires an interdisciplinary approach to identifying causes of racial biases and teaching health care professionals to recognize and reduce them.
AMA J Ethics. 2015;17(3):221-228. doi:
10.1001/journalofethics.2015.17.3.medu1-1503.
Concerns about the deleterious effects of stress on the mind and body have led to the beginnings of a stress vaccine, an injection that will reduce these effects.
David Elkin, MD, Erick Hung, MD, and Gilbert Villela, MD
The rapidly evolving field of neuroethics is concerned with the ethical questions that new technologies will pose about autonomy, privacy, the definition of normal, and individuality.
This month theme issue editor, Trahern Jones, a fourth-year student at Mayo Medical School in Rochester, Minnesota, spoke with Dr. Edward Laskowski about the use of performance-enhancing drugs and substances among athletes today.
The widespread perception that Jewish law unequivocally demands that all measures must be taken to prolong the life of a dying patient, even if they will prolong dying or cause suffering, is incorrect.